There is also strong evidence showing the activation of MTOR cascade due to high levels of HER2 [38], which was supported by our findings through several mechanisms and pathways we identified in our HER2 + cancers that target MTOR and change glucose metabolism. The gene discussed is ERBB2; the disease is cancer.